ARK Genomic Revolution ETF
ARKG

$24.24

2.92%

Market Cap: $1.26B

0

Funds holding %

of 6,686 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

1.18% more ownership

Funds ownership: 40.44% [Q1] → 41.62% (+1.18%) [Q2]

10% less funds holding

Funds holding: 278 [Q1] → 251 (-27) [Q2]

19% less capital invested

Capital invested by funds: $662M [Q1] → $535M (-$127M) [Q2]

39% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 90

44% less call options, than puts

Call options by funds: $86.3M | Put options by funds: $154M

51% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 53

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for ARKG.

See Analyst Rankings

Financial journalist opinion

The Motley Fool

Almost Every Ark Fund Is Now Underperforming The Overall Market. Here's Why.

Ark Funds pull exclusively from different slivers of the technology sector that also tend to be the most volatile. Economic conditions can make a bigger performance difference over the long term than most investors might expect.

Almost Every Ark Fund Is Now Underperforming The Overall Market. Here's Why.

Zacks Investment Research

5 Technology ETFs at the Forefront of the August Rebound

Wall Street roared back after a sell-off early in the month as fears of recession eased. The technology sector, which bore the biggest brunt, rebounded strongly and once again led the market over the past week.

5 Technology ETFs at the Forefront of the August Rebound

Zacks Investment Research

5 Sector ETFs That Outperformed With Double-Digit Gains in July

July witnessed the "Great Rotation" in the U.S. stock market as investors shunned the hot technology stocks in favor of smaller companies and other sectors, which are the bigger beneficiaries of the Fed rate cuts.

5 Sector ETFs That Outperformed With Double-Digit Gains in July

Zacks Investment Research

Best ETFs of Last Week

Wall Street offered a mixed performance last week.

Best ETFs of Last Week

ARKG: A Genomics Play But Active Isn't Adding Value

Genomics is rapidly advancing, shaping our understanding of health, disease, and life itself. Consider investing in the ARK Genomic Revolution ETF for exposure to leading genomics companies. ARKG's active management may not be outperforming compared to passive genomics ETFs like PBE, with potential regulatory and concentration risks.

ARKG: A Genomics Play But Active Isn't Adding Value

BMO Transfers 3 BMO Mutual Fund ETF Series, Managed by ARK Investment Management, to Cboe Canada

TORONTO--(BUSINESS WIRE)---- $ARKG #Cboe--Cboe Canada is pleased to announce BMO has transferred three BMO mutual fund ETF series, trading under the symbols ARKK, ARKW, and ARKG to Cboe Canada.

BMO Transfers 3 BMO Mutual Fund ETF Series, Managed by ARK Investment Management, to Cboe Canada

The Motley Fool

Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and the Simplest Way You Can Avoid Making the Same Mistake

Despite touting growth themes in a growth-fueled market, ARK Invest's exchange-traded funds are noticeably trailing major benchmarks. Betting big on a few companies can lead to massively outsize gains or missed opportunities.

Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and the Simplest Way You Can Avoid Making the Same Mistake

Why investor appetite for commodity funds picked up despite ETF flows broadly seeing ‘pretty big drop' in April

Hello! This week's ETF Wrap digs into the slump in ETF flows in April and investor positioning around commodities as inflation worries persist.

Why investor appetite for commodity funds picked up despite ETF flows broadly seeing ‘pretty big drop' in April

The Motley Fool

3 Cathie Wood ETFs Just Hit 4-Month Lows. Are They Worth Buying Now?

There are better ways to approach innovation than the Ark Innovation ETF. The ARK Space Exploration & Innovation ETF is a balanced bet.

3 Cathie Wood ETFs Just Hit 4-Month Lows. Are They Worth Buying Now?

Zacks Investment Research

Time to Tap Healthcare ETFs on Nvidia's AI Ambition?

At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.

Time to Tap Healthcare ETFs on Nvidia's AI Ambition?

See News Rankings